CASTLE BIOSCIENCES, INC. Accrued Income Taxes, Current
CASTLE BIOSCIENCES, INC. (CSTL) had Accrued Income Taxes, Current of $1.25 million as of 2025-09-30, per its 10-Q filed 2025-11-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2025-11-03
- 2025-09-30: Accrued Income Taxes, Current $1.25M.
- 2025-06-30: Accrued Income Taxes, Current $1.19M.
- 2025-03-31: Accrued Income Taxes, Current $1.28M.
- 2024-12-31: Accrued Income Taxes, Current $1.08M.
| Period end | Accrued Income Taxes, Current | Accrued Income Taxes, Current as first filed |
|---|---|---|
| 2025-09-30 | $1.25M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $1.19M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $1.28M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $1.08M 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $401.00K 10-K · filed 2025-02-27 | |
| 2021-09-30 | $10.00K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $10.00K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $62.00K 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $62.00K 10-Q · filed 2021-11-08 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $79.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $79.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $79.00K 10-K · filed 2021-03-11 | |
| 2019-09-30 | $8.61K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $8.61K 10-Q · filed 2019-09-03 | |
| 2018-12-31 | $9.00K 10-K · filed 2020-03-10 | $8.61K 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |